HHealth Read More HIV can develop resistance to lenacapavir, but at a cost to the virusJanuary 22, 2026  Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game…
SScience Read More Giant amoeba-infecting viruses offer new clues to the origin of eukaryotic lifeJanuary 9, 2026 The origin of life on Earth becomes even more fascinating and complex as we peer into the mysterious…
BBusiness Read More New method could improve manufacturing of gene-therapy drugs | MIT NewsOctober 28, 2025 Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their…
HHealth Read More Unveiling the dual role of HIV integrase in viral replicationOctober 24, 2025 The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most…